Tags

Type your tag names separated by a space and hit enter

More is needed to complement the available therapies of spinal muscular atrophy.
Future Med Chem 2019; 11(22):2873-2876FM

Authors+Show Affiliations

Department of Biomedical Science, Iowa State University, Ames, IA 50011, USA.

Pub Type(s)

Editorial

Language

eng

PubMed ID

31668092

Citation

Singh, Ravindra N.. "More Is Needed to Complement the Available Therapies of Spinal Muscular Atrophy." Future Medicinal Chemistry, vol. 11, no. 22, 2019, pp. 2873-2876.
Singh RN. More is needed to complement the available therapies of spinal muscular atrophy. Future Med Chem. 2019;11(22):2873-2876.
Singh, R. N. (2019). More is needed to complement the available therapies of spinal muscular atrophy. Future Medicinal Chemistry, 11(22), pp. 2873-2876. doi:10.4155/fmc-2019-0239.
Singh RN. More Is Needed to Complement the Available Therapies of Spinal Muscular Atrophy. Future Med Chem. 2019;11(22):2873-2876. PubMed PMID: 31668092.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - More is needed to complement the available therapies of spinal muscular atrophy. A1 - Singh,Ravindra N, Y1 - 2019/10/31/ PY - 2019/11/2/pubmed PY - 2019/11/2/medline PY - 2019/11/1/entrez KW - AAV9 KW - ISS-N1 KW - Spinraza KW - gene therapy KW - nusinersen KW - oligonucleotide KW - spinal muscular atrophy (SMA) KW - survival motor neuron (SMN) SP - 2873 EP - 2876 JF - Future medicinal chemistry JO - Future Med Chem VL - 11 IS - 22 SN - 1756-8927 UR - https://www.unboundmedicine.com/medline/citation/31668092/More_is_needed_to_complement_the_available_therapies_of_spinal_muscular_atrophy L2 - https://www.future-science.com/doi/full/10.4155/fmc-2019-0239?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows